Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Graefen

Showing results (611-620 of 850) with videos related to

Pageof 85
Sort By:
European Urology Focus|August 2, 2021
Nomogram Predicting Downgrading in National Comprehensive Cancer Network High-risk Prostate Cancer Patients Treated with Radical ProstatectomyMike Wenzel, Christoph Würnschimmel, Francesco Chierigo, et al.
European Urology|February 5, 2013
Serum isoform [-2]proPSA derivatives significantly improve prediction of prostate cancer at initial biopsy in a total PSA range of 2-10 ng/ml: a multicentric European studyMassimo Lazzeri, Alexander Haese, Alexandre de la Taille, et al.
Oncotarget|March 13, 2015
Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancerChristoph Burdelski, Christian Strauss, Maria Christina Tsourlakis, et al.
Urologic Oncology|December 27, 2015
Very long-term survival patterns of young patients treated with radical prostatectomy for high-risk prostate cancerPaolo Dell'Oglio, Robert Jeffrey Karnes, Steven Joniau, et al.
Urologic Oncology|April 18, 2022
Survival trends in chemotherapy exposed metastatic bladder cancer patients and chemotherapy effect across different age, sex, and race/ethnicityGabriele Sorce, Francesco Chierigo, Rocco Simone Flammia, et al.
BJU International|April 14, 2025
Long-term outcomes of active surveillance for Grade Group 1 prostate cancer and the impact of the use of MRI on overtreatmentIvo I de Vos, Cristina Marenghi, Fabio Badenchini, et al.
Plos One|June 2, 2015
Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate CancersChristoph Burdelski, Erzen Bujupi, Maria Christina Tsourlakis, et al.
Medicina (Kaunas, Lithuania)|June 28, 2023
Impact of Age on Long-Term Urinary Continence after Robotic-Assisted Radical ProstatectomyCristina Cano Garcia, Mike Wenzel, Clara Humke, et al.
Current Oncology (Toronto, Ont.)|December 13, 2021
Correlation of Urine Loss after Catheter Removal and Early Continence in Men Undergoing Radical ProstatectomyBenedikt Hoeh, Felix Preisser, Mike Wenzel, et al.
Marine Drugs|December 22, 2022
New Guanidine Alkaloids Batzelladines O and P from the Marine Sponge <i>Monanchora pulchra</i> Induce Apoptosis and Autophagy in Prostate Cancer CellsSergey A Dyshlovoy, Larisa K Shubina, Tatyana N Makarieva, et al.
Pageof 85

Showing results (611-620 of 850) with videos related to

Sort By:
Pageof 85
European Urology Focus|August 2, 2021
Nomogram Predicting Downgrading in National Comprehensive Cancer Network High-risk Prostate Cancer Patients Treated with Radical ProstatectomyMike Wenzel, Christoph Würnschimmel, Francesco Chierigo, et al.
European Urology|February 5, 2013
Serum isoform [-2]proPSA derivatives significantly improve prediction of prostate cancer at initial biopsy in a total PSA range of 2-10 ng/ml: a multicentric European studyMassimo Lazzeri, Alexander Haese, Alexandre de la Taille, et al.
Oncotarget|March 13, 2015
Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancerChristoph Burdelski, Christian Strauss, Maria Christina Tsourlakis, et al.
Urologic Oncology|December 27, 2015
Very long-term survival patterns of young patients treated with radical prostatectomy for high-risk prostate cancerPaolo Dell'Oglio, Robert Jeffrey Karnes, Steven Joniau, et al.
Urologic Oncology|April 18, 2022
Survival trends in chemotherapy exposed metastatic bladder cancer patients and chemotherapy effect across different age, sex, and race/ethnicityGabriele Sorce, Francesco Chierigo, Rocco Simone Flammia, et al.
BJU International|April 14, 2025
Long-term outcomes of active surveillance for Grade Group 1 prostate cancer and the impact of the use of MRI on overtreatmentIvo I de Vos, Cristina Marenghi, Fabio Badenchini, et al.
Plos One|June 2, 2015
Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate CancersChristoph Burdelski, Erzen Bujupi, Maria Christina Tsourlakis, et al.
Medicina (Kaunas, Lithuania)|June 28, 2023
Impact of Age on Long-Term Urinary Continence after Robotic-Assisted Radical ProstatectomyCristina Cano Garcia, Mike Wenzel, Clara Humke, et al.
Current Oncology (Toronto, Ont.)|December 13, 2021
Correlation of Urine Loss after Catheter Removal and Early Continence in Men Undergoing Radical ProstatectomyBenedikt Hoeh, Felix Preisser, Mike Wenzel, et al.
Marine Drugs|December 22, 2022
New Guanidine Alkaloids Batzelladines O and P from the Marine Sponge <i>Monanchora pulchra</i> Induce Apoptosis and Autophagy in Prostate Cancer CellsSergey A Dyshlovoy, Larisa K Shubina, Tatyana N Makarieva, et al.
Pageof 85